nras-melanoma
Experiences with tunlametinib / HL-085 plus nivolumab after PD-1 failure
A cohort-style thread for families to describe what happened, what they asked, and what they wish they had known. Not a recommendation thread.
Share experience and questions. Do not tell another person what treatment to take, stop, combine, or dose. Medical decisions belong with the oncology team.
Pinned moderator note
This thread is for experience, not treatment advice.
The most useful posts describe conversations with clinicians, questions prepared, confusing moments, and what a family wishes it had understood earlier.
Cohort experience template
- Cancer
- Melanoma
- Mutation
- NRAS
- Drug cohort
- tunlametinib / HL-085 + nivolumab
- Care region
- China / cross-border care
- Treatment line
- After PD-1/PD-L1 failure
What was tried, where was it prescribed, was it explained as MEK inhibitor plus PD-1 inhibitor, what questions were useful, what changed after response or progression, and what do you wish you had asked earlier?
How this cohort model works — what to include, what not to, and verification (expand)
Stories can include
- What was tried and where care happened.
- What questions helped with the oncology team.
- Why treatment started or stopped, in the family's words.
Stories cannot include
- Instructions to start, stop, combine, or dose medicine.
- Claims that another family will respond the same way.
- Private medical documents or identifying details.
Verification
- New cohort threads require doctor-report verification.
- The report is deleted after verification.
- Only the verification outcome is retained.
Good cohort story checklist
What makes a story useful
- Cancer type, mutation, and subtype if known.
- Drug cohort and care country/region.
- Prior therapies before this cohort.
- Approximate duration in plain language.
- Why it started and why it stopped, if known.
- Side effects that were discussed with the care team.
- What your family wishes it asked earlier.
Report verification flow
Verification without report storage
- A thread starter selects a credible doctor report only for verification.
- The report is reviewed for authenticity and match to the stated cohort.
- The report file is deleted after verification.
- Only the outcome is retained: verified, needs more review, or rejected.
- Public text still goes through moderation before becoming visible.
Moderation tools planned
- Gives direct medical advice
- Dangerous treatment claim
- Dosage or stop-treatment instruction
- Miracle cure or scam
- Harassment
- Personal/private information
- Self-harm or crisis concern
Thread preview
This cohort thread is for lived experience. Please do not tell another family to start, stop, combine, or dose any medicine.
Replies
Write a reply
Questions this thread helps you ask
- Was this drug cohort used in the same treatment line?
- Was the mutation result actually documented?
- Was the treatment standard, trial-based, off-label, or country-specific?
- What did the family wish they had asked before starting?